Instil Bio Inc TIL

Healthcare Biotechnology

Instil Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies. The Company seeks to in-license/acquire and develop novel therapeutic candidates in diseases with significant unmet medical need. Its first such program is an engineered tumor infiltrating lymphocyte (TIL), cell therapy for the treatment of cancer. It is engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor (CoStAR), platform. The Company's lead CoStAR-TIL product candidate, ITIL-306, expresses a CoStAR molecule designed to recognize folate receptor alpha (Fra), a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC and renal cancer. CAR-T and TCR-T therapies are cell products composed of T cells that have been genetically engineered to recognize a specific cancer-related antigen on the surface of tumor cells.

NDAQ:TIL - Post by User

Instil Bio Inc

Bullboard Posts

Post by Guavaon Aug 25, 2011 7:37pm

304 Views

Post# 18980531

Tomorrow or next week!

It is a normal GPD day with a red market went few cents down... A good example is KAM with Wednesday late afternoon news release.. It is impressed those gold intercepts at the double double and supremo targets.. However the market did not react to KAM excellent news.. Good for GPD saving some news for tomorrow or next week.
Clear Creek will be next. They have not updated it since last May. Harlan will be second with amazed drill gold intercepts; and Livingston will be third one with a neat soil/stream sediment contour. Dreaming and dreaming.
It will not be more news of Brewery Creek until they re-calculate resources and updated the last 43-101 report.
If you did not buy today. I am so sorry for you. GPD is a good/green stock every Friday!

Bullboard Posts

Barrick Gold employees detained in Mali amid ongoing dispute